Australia Laws (Overview) — THC‑Free CBD 2025

This page provides a cautious orientation to Australia’s CBD framework with emphasis on products marketed as “THC‑free.” It is not legal or medical advice. Verify current requirements with the Therapeutic Goods Administration (TGA), Office of Drug Control (ODC), state/territory health authorities, and relevant legislation/regulations. Reviewed through early 2025.

Snapshot

Scheduling: CBD is scheduled under the Poisons Standard. Low‑dose CBD may be eligible for Schedule 3 (pharmacist‑only) where a product is entered on the ARTG; many other access routes remain Schedule 4 (prescription‑only).
Retail reality: Only ARTG‑listed S3 products can be supplied OTC by pharmacists; most CBD products in the market are prescription pathways (e.g., Authorised Prescriber/SAS) and not general consumer goods.
Enforcement/oversight: TGA regulates medicines and advertising; ODC covers narcotic control and licensing. States/territories implement additional rules.

What “THC‑free” means (lab vs. law)

“THC‑free” is a testing outcome, not a legal category. On a Certificate of Analysis (COA), Δ9‑THC (and often THCA) should be reported as Not Detected (ND) at the laboratory’s stated limit of quantitation (LOQ). ND ≠ zero. A THC‑free result does not, by itself, convert a product into an OTC category or exempt it from scheduling, ARTG entry, or labeling rules.

Related reading: LOQ vs LOD, How to verify ND claims.

Access pathways (high level)

Schedule 3 (S3) pharmacist‑only: Limited, specific CBD products that have been registered/entered on the ARTG may be supplied without a prescription through pharmacists, subject to pack and dose limits. Availability remains constrained.
Schedule 4 (S4) prescription‑only: Most CBD products are accessed via a prescriber under Authorised Prescriber or Special Access Scheme pathways. Products must meet relevant quality standards.
Other categories: Cosmetic‑style topicals with CBD are uncommon because CBD is treated as a scheduled substance; food/supplement positioning is generally not applicable under current federal policy.

Advertising and claims

Therapeutic advertising is tightly regulated. Disease or treatment claims can trigger enforcement. Pharmacist supply also follows specific advertising restrictions. Always follow TGA advertising rules and avoid unapproved claims.

Import, export, and travel

Commercial import/export: Subject to ODC/TGA requirements and permits where applicable. Do not assume that a THC‑free COA creates an import pathway.
Personal import/use: Strict rules apply. Prescription documentation may be required. Verify with TGA guidance before attempting any import.
Domestic travel: Carry original packaging and prescription/dispensing labels where relevant. Rules can vary by state/territory.

For general travel context: Travel hub, and for shipping: Shipping hub.

Testing, labeling, and documentation

Use batch‑matched, third‑party COAs that show cannabinoid profile, ND/LOQ for THC, dates, and lab accreditation. See How to read COAs.
Products supplied under medical frameworks should meet quality standards and labeling norms (identity, content, batch, storage).
“THC‑free” on a label should be supported by current COA(s). Method LOQ should be stated.

State/territory notes (examples to verify)

States/territories may add requirements for prescribing, dispensing, storage, or record‑keeping. Verify locally with health departments or pharmacy regulators before supply or use.

Driver testing awareness

Roadside programs target THC, not CBD. However, consumers should avoid driving if drowsy and remain aware of local enforcement. “THC‑free” reduces but does not absolutely eliminate testing risk because ND depends on laboratory limits and manufacturing controls. See CBD and Driving and Drug Testing & Compliance.

How to verify quickly

Obtain batch COA (potency and contaminants). Confirm Δ9‑THC (and THCA) as ND at a stated LOQ; lab accredited where possible.
Confirm the legal pathway (ARTG S3 vs S4). A THC‑free COA alone is not a green light for OTC sale.
Match batch/lot on the COA to the product label; check dates/signatures.

Related resources

FAQ

Is CBD available OTC in Australia?
Limited registered S3 products may be pharmacist‑only OTC. Most products remain prescription‑only.

Does “THC‑free” make a product unscheduled?
No. Scheduling and product category still apply regardless of ND‑THC on a COA.

Can I import a THC‑free CBD product for personal use?
Do not assume. Verify with TGA/ODC; prescriptions and permits may be required.

Will THC‑free CBD affect a drug test?
Programs target THC metabolites, not CBD, but no product can guarantee outcomes. See our testing overview.